Latest Earnings Results: Q2 '26
Estimated EPS
-$0.19
Reported EPS
-$0.13
Surprise
+32.09%
Estimated Rev
$17.8M
Reported Rev
$19.94M
Surprise
+12.03%
• Reported GAAP EPS of -$0.13 up 38.10% YoY • Reported revenue of $19.94M up 15.92% YoY • Exagen Inc. increased its full-year 2026 revenue guidance to a range of $72 million to $75 million, which compares to the company's previous guidance of $70 million to $73 million.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.18 | -- | -- | N/A |
Q2 '26 | -$0.19 | -$0.13 | 32.09% | BEAT |
Q1 '26 | -$0.23 | -$0.17 | 26.99% | BEAT |
Q4 '25 | -$0.19 | -$0.20 | -5.43% | MISSED |
Q3 '25 | -$0.16 | -$0.31 | -97.56% | MISSED |